Jody Liu

Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against autoimmune diseases

Zhe-Sheng Chen, Ronghan Liu, Yuehong Chen, 2019, bioRxiv.

TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity.

P. Loke, D. Solit, G. Xiao, 2021, The Journal of clinical investigation.

Thrombin-Activated Platelets Protect Vascular Endothelium against Tumor Cell Extravasation by Targeting Endothelial VCAM-1

Hsin-Hsin Peng, Chiou-Mei Lee, Ren-Hao Chen, 2022, International journal of molecular sciences.

Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis

Zhe-Sheng Chen, G. Xiao, Xiangli Zhao, 2019, Annals of the rheumatic diseases.